Nope. No PDD readout by EOY IMO. Calendar does not lie. Today closes out another week. Rett so far behind Neuren won't be worth much even if good news which I hope it is. Really looking forward to them running a trial in the most affected aged girls but doesn't look like too soon on that. Happy New Year!
I can't imagine being invested in a bio stock this many years and having to go on pre clinical evidence alone without any controlled trial results.
Market Data 
Markets 
AI
